KCP
PFE icon

Kera Capital Partners’s Pfizer PFE Stock Holding History

Kera Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$513K Buy
21,323
+9,500
+80% +$249K 0.05% 315
2026
Q1 		$332K Buy
11,823
+73
+0.6% +$1.94K 0.04% 377
2025
Q4 		$311K Sell
11,750
-4,720
-29% -$119K 0.04% 391
2025
Q3 		$420K Buy
+16,470
New +$407K 0.06% 193

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kera Capital Partners's PFE Position: Q2 2026 in Review

Kera Capital Partners increased its Pfizer (PFE) stake by 80% in Q2 2026, buying an estimated $249K and bringing the position to 21,323 shares worth $513K. The position accounts for 0.05% of the portfolio, ranked #315.

Kera Capital Partners first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Kera Capital Partners held 21,323 shares of Pfizer worth $513K as of Q2 2026.
  • Kera Capital Partners bought 9,500 Pfizer shares in Q2 2026, an estimated $249K.
  • Pfizer made up 0.05% of Kera Capital Partners's portfolio in Q2 2026, its #315 holding.
  • Kera Capital Partners first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.